Compare with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES DISHMAN PHARMA ALKEM LABORATORIES/
DISHMAN PHARMA
 
P/E (TTM) x 24.4 25.1 97.3% View Chart
P/BV x 5.9 3.3 176.0% View Chart
Dividend Yield % 0.8 0.7 124.0%  

Financials

 ALKEM LABORATORIES   DISHMAN PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-20
DISHMAN PHARMA
Mar-16
ALKEM LABORATORIES/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs2,720374 726.5%   
Low Rs1,660129 1,288.1%   
Sales per share (Unadj.) Rs697.9197.8 352.8%  
Earnings per share (Unadj.) Rs96.121.2 453.3%  
Cash flow per share (Unadj.) Rs117.334.7 337.7%  
Dividends per share (Unadj.) Rs25.002.00 1,250.0%  
Dividend yield (eoy) %1.10.8 143.6%  
Book value per share (Unadj.) Rs515.2179.9 286.4%  
Shares outstanding (eoy) m119.5780.69 148.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.11.3 246.7%   
Avg P/E ratio x22.811.9 192.0%  
P/CF ratio (eoy) x18.77.2 257.7%  
Price / Book Value ratio x4.31.4 303.9%  
Dividend payout %26.09.4 275.8%   
Avg Mkt Cap Rs m261,87920,306 1,289.7%   
No. of employees `00014.30.8 1,728.7%   
Total wages/salary Rs m15,0555,355 281.1%   
Avg. sales/employee Rs Th5,822.619,252.7 30.2%   
Avg. wages/employee Rs Th1,050.56,459.5 16.3%   
Avg. net profit/employee Rs Th802.02,064.1 38.9%   
INCOME DATA
Net Sales Rs m83,44415,961 522.8%  
Other income Rs m1,042265 392.7%   
Total revenues Rs m84,48616,226 520.7%   
Gross profit Rs m14,7344,103 359.1%  
Depreciation Rs m2,5281,091 231.8%   
Interest Rs m651944 68.9%   
Profit before tax Rs m12,5982,334 539.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,105624 177.2%   
Profit after tax Rs m11,4931,711 671.7%  
Gross profit margin %17.725.7 68.7%  
Effective tax rate %8.826.7 32.8%   
Net profit margin %13.810.7 128.5%  
BALANCE SHEET DATA
Current assets Rs m54,96011,018 498.8%   
Current liabilities Rs m32,4339,517 340.8%   
Net working cap to sales %27.09.4 287.1%  
Current ratio x1.71.2 146.4%  
Inventory Days Days80110 72.0%  
Debtors Days Days7235 207.1%  
Net fixed assets Rs m32,71016,304 200.6%   
Share capital Rs m239161 148.1%   
"Free" reserves Rs m61,36812,907 475.5%   
Net worth Rs m61,60714,516 424.4%   
Long term debt Rs m1,5924,189 38.0%   
Total assets Rs m99,43329,805 333.6%  
Interest coverage x20.43.5 586.7%   
Debt to equity ratio x00.3 9.0%  
Sales to assets ratio x0.80.5 156.7%   
Return on assets %12.28.9 137.1%  
Return on equity %18.711.8 158.3%  
Return on capital %21.017.5 119.6%  
Exports to sales %19.124.8 77.0%   
Imports to sales %3.03.7 79.6%   
Exports (fob) Rs m15,9173,956 402.3%   
Imports (cif) Rs m2,483596 416.4%   
Fx inflow Rs m16,0614,952 324.4%   
Fx outflow Rs m2,483697 356.3%   
Net fx Rs m13,5784,255 319.1%   
CASH FLOW
From Operations Rs m5,8512,786 210.0%  
From Investments Rs m-7,414-1,529 484.9%  
From Financial Activity Rs m792-941 -84.1%  
Net Cashflow Rs m-731316 -231.1%  

Share Holding

Indian Promoters % 66.9 61.4 109.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 3.7 894.6%  
FIIs % 0.0 12.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 22.1 -  
Shareholders   68,381 46,261 147.8%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   NATCO PHARMA  STRIDES PHARMA SCIENCE  TTK HEALTHCARE  TORRENT PHARMA  BIOCON   

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Over 500 Points Lower; Dow Futures Down by 77 Points(12:30 pm)

Share markets in India are presently trading on a negative note. The BSE Sensex is trading down by 553 points, down 1.1% at 47,794 levels.

Related Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

One Chart to See Before You Sell(Fast Profits Daily)

Jan 22, 2021

In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.

Invest in the Multibaggers of 2021 and Beyond(Profit Hunter)

Jan 21, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jan 27, 2021 12:30 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS